Lu Lu

20.3k total citations · 8 hit papers
305 papers, 11.8k citations indexed

About

Lu Lu is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lu Lu has authored 305 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Infectious Diseases, 71 papers in Virology and 59 papers in Epidemiology. Recurrent topics in Lu Lu's work include HIV Research and Treatment (69 papers), SARS-CoV-2 and COVID-19 Research (61 papers) and HIV/AIDS drug development and treatment (50 papers). Lu Lu is often cited by papers focused on HIV Research and Treatment (69 papers), SARS-CoV-2 and COVID-19 Research (61 papers) and HIV/AIDS drug development and treatment (50 papers). Lu Lu collaborates with scholars based in China, United States and Hong Kong. Lu Lu's co-authors include Shibo Jiang, Shuai Xia, Lanying Du, Wei Xu, Yun Zhu, Tianlei Ying, Zheng‐Li Shi, Yanling Wu, Qian Wang and Qiaoshuai Lan and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lu Lu

290 papers receiving 11.6k citations

Hit Papers

Inhibition of SARS-CoV-2 ... 2014 2026 2018 2022 2020 2020 2020 2019 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
    2020 978 citations Shuai Xia, Chao Wang et al. profile →
  2. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
    2020 838 citations Xiaolong Tian, Cheng Li et al. Emerging Microbes & Infections profile →
  3. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
    2020 518 citations Shuai Xia, Yun Zhu et al. profile →
  4. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
    2019 374 citations Shuai Xia, Wei Xu et al. profile →
  5. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
    2021 334 citations Wei Xu, Shibo Jiang et al. profile →
  6. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
    2019 333 citations Da Xu, Yan Zheng et al. profile →
  7. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
    2014 317 citations Lu Lu, Yun Zhu et al. profile →
  8. Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients
    2021 234 citations Lu Lu, Bobo Wing-Yee Mok et al. Clinical Infectious Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lu Lu 6.6k 3.1k 1.9k 1.6k 1.1k 305 11.8k
Wayne A. Marasco 3.8k 0.6× 4.2k 1.4× 2.7k 1.5× 2.2k 1.3× 851 0.8× 165 11.3k
Peng Zhou 6.3k 1.0× 1.6k 0.5× 1.1k 0.6× 1.6k 1.0× 420 0.4× 172 10.4k
Zhiwei Chen 4.1k 0.6× 3.2k 1.0× 2.2k 1.2× 1.8k 1.1× 2.2k 2.1× 396 11.6k
Graham Simmons 5.7k 0.9× 1.4k 0.5× 3.0k 1.6× 1.7k 1.1× 2.3k 2.2× 132 10.0k
Yuxian He 9.0k 1.3× 2.4k 0.8× 2.2k 1.2× 1.6k 1.0× 3.0k 2.8× 153 11.9k
Hans Wilhelm Doerr 3.7k 0.6× 1.9k 0.6× 1.4k 0.7× 3.2k 2.0× 1.0k 0.9× 263 9.6k
Jianhua Sui 5.7k 0.9× 2.5k 0.8× 1.8k 1.0× 4.0k 2.5× 251 0.2× 77 11.7k
Hin Chu 6.3k 1.0× 1.8k 0.6× 1.3k 0.7× 1.4k 0.9× 280 0.3× 126 9.2k
Yi Shi 4.1k 0.6× 2.8k 0.9× 1.5k 0.8× 3.4k 2.1× 274 0.3× 199 9.8k
Xinquan Wang 5.8k 0.9× 3.4k 1.1× 1.8k 1.0× 816 0.5× 193 0.2× 134 10.3k

Countries citing papers authored by Lu Lu

Since Specialization
Citations

This map shows the geographic impact of Lu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Lu more than expected).

Fields of papers citing papers by Lu Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Lu. The network helps show where Lu Lu may publish in the future.

Co-authorship network of co-authors of Lu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Lu. A scholar is included among the top collaborators of Lu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Lu. Lu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ling, Haiyan Qiu, Yang Hong, et al.. (2025). The effects of maternal health literacy, family functioning and self-efficacy on antepartum depression in pregnant women in China: a moderated mediation model. BMC Psychiatry. 25(1). 101–101. 1 indexed citations
2.
Liu, Xiaoyue Cathy, et al.. (2025). A Self-Supervised Multi-Agent Large Language Model Framework for Customized Traffic Mobility Analysis Using Machine Learning Models. Transportation Research Record Journal of the Transportation Research Board. 2679(7). 1–16. 1 indexed citations
3.
Xu, Hao, Hao Wang, Shuwan Yu, et al.. (2025). Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma. European Radiology. 35(7). 4121–4131. 2 indexed citations
4.
Lu, Lu, Mingjie Chen, Guicheng Zhang, et al.. (2024). Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression. Scientific Reports. 14(1). 28519–28519. 1 indexed citations
5.
Wang, Shun, Yan Zheng, Da Xu, et al.. (2024). Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma. Cell Reports Medicine. 5(2). 101415–101415. 42 indexed citations
6.
Yang, Luyu, Xiaotian Shen, Junjie Pan, et al.. (2024). Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 12(8). e009642–e009642. 8 indexed citations
7.
8.
9.
Lu, Lu, et al.. (2023). A multi-scale perceptual polyp segmentation network based on boundary guidance. Image and Vision Computing. 138. 104811–104811. 12 indexed citations
10.
Liu, Zezhong, Jie Zhou, Xinling Wang, et al.. (2023). A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates. Proceedings of the National Academy of Sciences. 120(11). e2221713120–e2221713120. 16 indexed citations
11.
12.
Lu, Lu, Bobo Wing-Yee Mok, Jacky Man Chun Chan, et al.. (2021). Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients. Clinical Infectious Diseases. 75(1). e822–e826. 234 indexed citations breakdown →
13.
14.
Wang, Ji, Peiyu Li, Yang Yu, et al.. (2020). Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 367(6480). 237 indexed citations
15.
Tang, Jie, Jin Liu, Yun Ma, et al.. (2020). Exosomes Derived from Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Inhibiting Pyroptosis. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Tian, Xiaolong, Cheng Li, Ailing Huang, et al.. (2020). Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging Microbes & Infections. 9(1). 382–385. 838 indexed citations breakdown →
17.
Wang, Qian, Shan Su, Jing Xue, et al.. (2020). An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells. Science Translational Medicine. 12(546). 11 indexed citations
18.
Pu, Jing, Yue Li, Wei Xu, et al.. (2019). Design and Biological Evaluation of m-Xylene Thioether-Stapled Short Helical Peptides Targeting the HIV-1 gp41 Hexameric Coiled–Coil Fusion Complex. Journal of Medicinal Chemistry. 62(19). 8773–8783. 17 indexed citations
19.
Delprato, Anna, et al.. (2017). QTLand systems genetics analysis of mouse grooming and behavioral responses to novelty in an open field. Genes Brain & Behavior. 16(8). 790–799. 18 indexed citations
20.
Tao, Xinrong, Tania Garron, Anurodh Shankar Agrawal, et al.. (2015). Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. Journal of Virology. 90(1). 57–67. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wayne A. Marasco Breakdown of academic impact, for papers by Peng Zhou Breakdown of academic impact, for papers by Zhiwei Chen Breakdown of academic impact, for papers by Graham Simmons Breakdown of academic impact, for papers by Yuxian He Breakdown of academic impact, for papers by Hans Wilhelm Doerr Breakdown of academic impact, for papers by Jianhua Sui Breakdown of academic impact, for papers by Hin Chu Breakdown of academic impact, for papers by Yi Shi Breakdown of academic impact, for papers by Xinquan Wang
Rankless by CCL
2026